Cordlife Sciences India Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 45.35 Cr
as on 24-10-2024
- Company Age 19 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.00 Cr
as on 24-10-2024
- Revenue -0.48%
(FY 2023)
- Profit -318.58%
(FY 2023)
- Ebitda -68.22%
(FY 2023)
- Net Worth -18.84%
(FY 2023)
- Total Assets 8.49%
(FY 2023)
About Cordlife Sciences India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 45.35 Cr.
The company has closed loans amounting to ₹3.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cordlife Sciences India Pvt Ltd India is Amit Srivastava as CEO. Prosanto Chowdhury and Vishal Kanodia serve as directors at the Company.
- CIN/LLPIN
U85196WB2005PTC106719
- Company No.
106719
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2005
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cordlife Sciences India Pvt Ltd offer?
Cordlife Sciences India Pvt Ltd offers a wide range of products and services, including .
Who are the key members and board of directors at Cordlife Sciences India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Srivastava | CEO | 01-Oct-2022 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prosanto Chowdhury  | Director | 30-Dec-2020 | Current |
| Vishal Kanodia | Director | 17-Oct-2024 | Current |
Financial Performance of Cordlife Sciences India.
Cordlife Sciences India Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.48% decrease. The company also saw a substantial fall in profitability, with a 318.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cordlife Sciences India?
In 2023, Cordlife Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 23 Feb 2018 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Cordlife Sciences India?
Cordlife Sciences India has a workforce of 349 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cordlife Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cordlife Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
